Eli Lilly expects FDA to apply for Zepbound for sleep apnea in the short term
Eli Lilly On Friday it said it applied for U.S. approval of its weight-loss drug Zepbound for the treatment of…
business news
Citigroup, JPMorgan Chase and Goldman hit by regulators
Citigroup CEO Jane Fraser testifies during the Senate Banking, Housing and Urban Affairs Committee hearing titled Annual Oversight of the…
Home prices hit record highs in May as sales stagnate
Existing home sales are at their lowest level in 30 years and didn't budge much in May as prices hit…
Forever 21 seeks rent concessions, facing financial difficulties
A Forever 21 store in London on September 30, 2019. Alberto Pezzali | NurPhoto | fake images Forever 21 is…
Shein's US IPO is dead, experts say
The Shein logo can be seen on a smartphone, while the Chinese online retailer's website is open on a laptop.…
Paradromics prepares to test its brain implant in humans
Neurotech startup Paradromics will test its brain implant next year, as the race to be a leader in the nascent…
SpaceX Unveils 'Starlink Mini' Satellite Internet Antenna for $599
Starlink Mini promotional image. SpaceX customer email sent June 19, 2024. SpaceX is launching a compact version of its Starlink…
Catalyst Calendar: Here's a Look at the Major Events That Could Drive These 7 Stocks Higher
AI technology stocks have been all the rage on Wall Street. But here are some events that could boost other…
Fast-food diners switching to casual chains, Darden CEO says
Customers arrive at an Olive Garden location in San Antonio, Texas. Callaghan O'Hare | Bloomberg | fake images Casual restaurant…
Gilead PrEP lenacapavir succeeds in phase 3 trial
The logo of the pharmaceutical company Gilead Sciences in Oceanside, California, on April 29, 2020. Mike Blake | Reuters GileadThe…